Press Play with Madeleine Brand
Johnson & Johnson Under Fire
In 1994, Johnson & Johnson started selling an anti-psychotic drug called Risperdal. The FDA approved it for adults with schizophrenia, but it expressly forbade Johnson & Johnson from marketing Risperdal to treat children and the elderly—there were too many dangerous side effects.
In 1994, Johnson & Johnson started selling an anti-psychotic drug called Risperdal. The FDA approved it for adults with schizophrenia, but it expressly forbade Johnson & Johnson from marketing Risperdal to treat children and the elderly—there were too many dangerous side effects. Nevertheless, for more than a decade, that’s exactly what Johnson & Johnson did. And despite government sanctions for its behavior, and thousands of lawsuits, the company made billions in profits.
The full episode
2 of 5- 0:00Volkswagen Fraud
- 9:01Johnson & Johnson Under FireYou’re reading this
- 23:27Paxil Unsafe for Teenagers
- 33:48Undercover Uber
- 40:47TV Roundup: The Emmys